Development of new antituberculosis drugs among of 1,3- and 1,4-diazines. Highlights and perspectives
Crossref DOI link: https://doi.org/10.1007/s11172-019-2686-x
Published Online: 2020-02-06
Published Print: 2019-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Verbitskiy, E. V.
Rusinov, G. L.
Charushin, V. N.
Chupakhin, O. N.
Text and Data Mining valid from 2019-12-01
Version of Record valid from 2019-12-01
Article History
Received: 6 September 2019
Revised: 14 October 2019
Accepted: 8 November 2019
First Online: 6 February 2020